rs10774907
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000620.5(NOS1):c.*5711C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.312 in 985,350 control chromosomes in the GnomAD database, including 58,381 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.46 ( 21045 hom., cov: 33)
Exomes 𝑓: 0.29 ( 37336 hom. )
Consequence
NOS1
NM_000620.5 3_prime_UTR
NM_000620.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.239
Publications
6 publications found
Genes affected
NOS1 (HGNC:7872): (nitric oxide synthase 1) The protein encoded by this gene belongs to the family of nitric oxide synthases, which synthesize nitric oxide from L-arginine. Nitric oxide is a reactive free radical, which acts as a biologic mediator in several processes, including neurotransmission, and antimicrobial and antitumoral activities. In the brain and peripheral nervous system, nitric oxide displays many properties of a neurotransmitter, and has been implicated in neurotoxicity associated with stroke and neurodegenerative diseases, neural regulation of smooth muscle, including peristalsis, and penile erection. This protein is ubiquitously expressed, with high level of expression in skeletal muscle. Multiple transcript variants that differ in the 5' UTR have been described for this gene but the full-length nature of these transcripts is not known. Additionally, alternatively spliced transcript variants encoding different isoforms (some testis-specific) have been found for this gene.[provided by RefSeq, Feb 2011]
NOS1 Gene-Disease associations (from GenCC):
- idiopathic achalasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.852 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NOS1 | NM_000620.5 | c.*5711C>T | 3_prime_UTR_variant | Exon 29 of 29 | ENST00000317775.11 | NP_000611.1 | ||
| NOS1 | NM_001204218.2 | c.*5711C>T | 3_prime_UTR_variant | Exon 30 of 30 | NP_001191147.1 | |||
| NOS1 | NM_001204213.2 | c.*5711C>T | 3_prime_UTR_variant | Exon 28 of 28 | NP_001191142.1 | |||
| NOS1 | NM_001204214.2 | c.*5711C>T | 3_prime_UTR_variant | Exon 28 of 28 | NP_001191143.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.456 AC: 69333AN: 152112Hom.: 20980 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
69333
AN:
152112
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.286 AC: 237931AN: 833118Hom.: 37336 Cov.: 31 AF XY: 0.284 AC XY: 109422AN XY: 384722 show subpopulations
GnomAD4 exome
AF:
AC:
237931
AN:
833118
Hom.:
Cov.:
31
AF XY:
AC XY:
109422
AN XY:
384722
show subpopulations
African (AFR)
AF:
AC:
14294
AN:
15786
American (AMR)
AF:
AC:
413
AN:
984
Ashkenazi Jewish (ASJ)
AF:
AC:
889
AN:
5152
East Asian (EAS)
AF:
AC:
1784
AN:
3628
South Asian (SAS)
AF:
AC:
3920
AN:
16460
European-Finnish (FIN)
AF:
AC:
85
AN:
276
Middle Eastern (MID)
AF:
AC:
342
AN:
1622
European-Non Finnish (NFE)
AF:
AC:
207972
AN:
761912
Other (OTH)
AF:
AC:
8232
AN:
27298
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
10120
20239
30359
40478
50598
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
9650
19300
28950
38600
48250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.456 AC: 69461AN: 152232Hom.: 21045 Cov.: 33 AF XY: 0.452 AC XY: 33674AN XY: 74434 show subpopulations
GnomAD4 genome
AF:
AC:
69461
AN:
152232
Hom.:
Cov.:
33
AF XY:
AC XY:
33674
AN XY:
74434
show subpopulations
African (AFR)
AF:
AC:
35714
AN:
41570
American (AMR)
AF:
AC:
7202
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
637
AN:
3468
East Asian (EAS)
AF:
AC:
2510
AN:
5176
South Asian (SAS)
AF:
AC:
1183
AN:
4830
European-Finnish (FIN)
AF:
AC:
3022
AN:
10592
Middle Eastern (MID)
AF:
AC:
77
AN:
294
European-Non Finnish (NFE)
AF:
AC:
17992
AN:
67982
Other (OTH)
AF:
AC:
828
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1498
2995
4493
5990
7488
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
550
1100
1650
2200
2750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1395
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.